TekniPlex Healthcare, which utilizes advanced materials science expertise to help deliver better patient outcomes, has completed its acquisition of Seisa Medical in a deal that significantly extends TekniPlex Healthcare’s medical technology solutions platform. This acquisition specifically enhances the company’s materials science and process technologies for minimally invasive and interventional therapy devices on a global scale.
Based in El Paso, Texas, Seisa is a medical device manufacturer servicing every stage of the product life cycle including design and development, component manufacturing, and final assembly. It employs more than 2,000 people across four facilities in the U.S., Mexico and Slovakia.
“This acquisition elevates TekniPlex Healthcare into a full-fledged contract development manufacturing organization in the medical materials science space,” said Chris Qualters, CEO for TekniPlex Healthcare. “Seisa’s broad portfolio in the burgeoning interventional technologies niche – including its prowess with stent grafts, mitral heart valves, endovascular procedures and cardiovascular catheter delivery systems – complement our legacy capabilities exceptionally well. Combining Seisa’s strengths with ours allows us to more comprehensively engage with customers to develop engineered materials, co-design components and assemblies, and provide sterile barrier products, among other categories.”
